Stocks · US
CAH
XNYS
Cardinal Health, Inc.
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E31.49x
P/B—
P/S0.21x
EPS$7.40
ROE-59.45%
ROA2.99%
Dividend yield0.91%
EV/EBITDA15.10x
Debt/Equity-3.08
Free cash flow$4.5B
Returns and 52-week range
1W+4.26%
1M-5.56%
3M-1.56%
6M+9.71%
1Y+51.13%
YTD+13.47%
52W high$258.30
52W low$151.87
From 52W high-9.63%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| Cencora, Inc. | $60.1B | 22.90 | 19.70 | -4.41% |
| Edwards Lifesciences Corp | $50.3B | 50.03 | 4.74 | -3.80% |
| Natera, Inc. Common Stock | $61.4B | — | 33.68 | +22.08% |
| Becton, Dickinson and Co. | $49.2B | 52.30 | 2.02 | -2.40% |
| 보스턴 사이언티픽 | $61.4B | 16.72 | 2.46 | -11.74% |
| 휴마나 | $48.5B | 37.94 | 2.53 | +0.68% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.